ACAD
39.86
-2.07
-4.94%
AEMD
6.55
-0.09
-1.43%
APRI
1.67
-0.08
-4.57%
ARNA
4.3
-0.09
-2.05%
ATEC
1.38
+0.01
+0.73%
CNAT
5.11
-0.32
-5.89%
CRXM
0.377
0.00
0.00%
CYTX
0.56
-0.03
-5.08%
DXCM
79.1
-0.5
-0.63%
GNMK
9.1
-0.39
-4.11%
HALO
21.24
+0.1
+0.47%
ILMN
213.98
-4.08
-1.87%
INNV
0.117
-0.004
-2.9167%
INO
7.99
-0.51
-6.00%
ISCO
0.041
-0.002
-5.312%
ISIS
56.05
-2.84
-4.82%
LGND
96.8
-2.51
-2.53%
LPTN
0.26
-0.027
-9.4458%
MBVX
2.33
+0.1
+4.48%
MEIP
1.7
-0.05
-2.86%
MNOV
3.97
-0.26
-6.15%
MRTX
30.86
-0.31
-0.99%
MSTX
0.47
-0.005
-1.0947%
NBIX
45.81
-0.91
-1.95%
NUVA
47.6
-1.42
-2.90%
ONCS
6.42
-0.48
-6.96%
ONVO
3.65
-0.28
-7.12%
OREX
4.54
-0.21
-4.42%
OTIC
21.1
-0.38
-1.77%
QDEL
22.85
-0.22
-0.95%
RCPT
176
-7.83
-4.26%
RGLS
10.11
-0.16
-1.56%
RMD
55.44
-0.45
-0.81%
SCIE
0.018
-0.001
-6.6327%
SPHS
0.81
-0.09
-10.00%
SRNE
16.57
-0.33
-1.95%
TROV
9.23
+0.09
+0.98%
VICL
0.7
0.00
0.00%
ZGNX
1.62
-0.05
-2.99%
ACAD
39.86
-2.07
-4.94%
AEMD
6.55
-0.09
-1.43%
APRI
1.67
-0.08
-4.57%
ARNA
4.3
-0.09
-2.05%
ATEC
1.38
+0.01
+0.73%
CNAT
5.11
-0.32
-5.89%
CRXM
0.377
0.00
0.00%
CYTX
0.56
-0.03
-5.08%
DXCM
79.1
-0.5
-0.63%
GNMK
9.1
-0.39
-4.11%
HALO
21.24
+0.1
+0.47%
ILMN
213.98
-4.08
-1.87%
INNV
0.117
-0.004
-2.9167%
INO
7.99
-0.51
-6.00%
ISCO
0.041
-0.002
-5.312%
ISIS
56.05
-2.84
-4.82%
LGND
96.8
-2.51
-2.53%
LPTN
0.26
-0.027
-9.4458%
MBVX
2.33
+0.1
+4.48%
MEIP
1.7
-0.05
-2.86%
MNOV
3.97
-0.26
-6.15%
MRTX
30.86
-0.31
-0.99%
MSTX
0.47
-0.005
-1.0947%
NBIX
45.81
-0.91
-1.95%
NUVA
47.6
-1.42
-2.90%
ONCS
6.42
-0.48
-6.96%
ONVO
3.65
-0.28
-7.12%
OREX
4.54
-0.21
-4.42%
OTIC
21.1
-0.38
-1.77%
QDEL
22.85
-0.22
-0.95%
RCPT
176
-7.83
-4.26%
RGLS
10.11
-0.16
-1.56%
RMD
55.44
-0.45
-0.81%
SCIE
0.018
-0.001
-6.6327%
SPHS
0.81
-0.09
-10.00%
SRNE
16.57
-0.33
-1.95%
TROV
9.23
+0.09
+0.98%
VICL
0.7
0.00
0.00%
ZGNX
1.62
-0.05
-2.99%
Home » Archive by Category

Xconomy

Companion Medical Raises $3M to Get Its Smart Insulin Pen to Market

May 20, 2015 – 9:58 pm

Companion Medical, a San Diego medical device startup founded about 16 months ago, has raised $3 million in an ongoing Series B financing round led by an investment from Eli Lilly, according to a…

[[Click headline to continue reading.]]

Celgene to Use Cypher Genomics’ Data Analytics in Drug Development

May 20, 2015 – 5:00 am

Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey’s Celgene (NASDAQ: CELG) identify key genetic variants…

[[Click headline to continue reading.]]

Celgene to Use Cypher Genomics’ Data Analytics in Drug Development

May 20, 2015 – 5:00 am

Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey’s Celgene (NASDAQ: CELG) identify key genetic variants…

[[Click headline to continue reading.]]

Fate Therapeutics, Riding High on Juno Deal, Raising More Cash

May 19, 2015 – 8:41 am

Taking advantage of a healthy bounce on Wall Street, San Diego’s Fate Therapeutics (NASDAQ: FATE) said Monday it plans to sell 6 million shares of its common stock through a secondary public…

[[Click headline to continue reading.]]

Fate Therapeutics, Riding High on Juno Deal, Raising More Cash

May 19, 2015 – 8:41 am

Taking advantage of a healthy bounce on Wall Street, San Diego’s Fate Therapeutics (NASDAQ: FATE) said Monday it plans to sell 6 million shares of its common stock through a secondary public…

[[Click headline to continue reading.]]

Four Tough Questions Startup CEOs Need to Ask to Scale

May 19, 2015 – 7:26 am

Mark Organ thinks very differently about how to evolve as a founder-CEO now that he’s on his second company. A decade ago, Mark co-founded customer relations management software company Eloqua. “I…

[[Click headline to continue reading.]]

Still Room For Great Guests at Napa Summit 2015—Request An Invite

May 18, 2015 – 6:43 am

“It’s like a mini-Davos.” That’s the way one leading venture capitalist describes Xconomy’s Napa Summit. And while he is perhaps a bit effusive, we do believe our annual retreat in wine country is…

[[Click headline to continue reading.]]

Talking Cure? For Cancer Immunotherapy, Still Many Rivers to Cross

May 12, 2015 – 3:30 am

Cancer is a humbling thing: Our own cells gone bad, killing us from the inside, and so often able to rebound from attack or avoid it entirely. There has been progress fighting some types of cancers,…

[[Click headline to continue reading.]]

Reflections on the “Build to Buy,” Part 2: The Applicability Problem

April 30, 2015 – 3:35 am

In a prior Xconomy post, I explored the unwritten and often hidden challenges of successfully navigating and completing a ‘build to buy’ acquisition. The fundamental issue that underlies those…

[[Click headline to continue reading.]]

Preeclampsia Test Developer Carmenta Bought For Undisclosed Sum

April 29, 2015 – 12:42 pm

Any expectant parent knows that preeclampsia—a kind of high blood pressure during pregnancy—is a dreaded possibility. It can be fatal for mother and baby, and it can be difficult to…

[[Click headline to continue reading.]]